- Home
- BMY vs MO Comparison
BMY vs MO Comparison
Compare BMY & MO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMY | MO |
|---|---|---|
| Founded | 1887 | 1822 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0B | 98.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BMY | MO |
|---|---|---|
| Price | $60.54 | $67.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $59.93 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 13.5M | 11.1M |
| Earning Date | 02-05-2026 | 01-29-2026 |
| Dividend Yield | 4.15% | ★ 6.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | 3.46 | ★ 4.12 |
| Revenue | ★ $48,194,000,000.00 | $20,139,000,000.00 |
| Revenue This Year | N/A | $3.27 |
| Revenue Next Year | N/A | $0.40 |
| P/E Ratio | $17.55 | ★ $16.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $42.52 | $52.40 |
| 52 Week High | $63.33 | $68.60 |
Technical Indicators
Market Signals| Indicator | BMY | MO |
|---|---|---|
| Relative Strength Index (RSI) | 65.95 | 68.13 |
| Support Level | $59.25 | $63.60 |
| Resistance Level | $62.05 | $67.46 |
| Average True Range (ATR) | 1.38 | 1.58 |
| MACD | 0.30 | 0.26 |
| Stochastic Oscillator | 77.81 | 90.87 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MO Altria Group Inc.
Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.